Apogee Therapeutics, Inc. - 8-K Filing
Apogee Therapeutics completed a $135.11/share merger with AbbVie subsidiary on September 3, 2026 for total equity value of ~$10.9B (Items: 1.02 Termination of a Material Definitive Agreement, 2.01 Completion of Acquisition or Disposition of Assets, 5.02 and Item 5, 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing)
Tickers: $APGE